期刊文献+

反义微小RNA-21寡核苷酸对食管癌EC9706细胞生长的抑制作用 被引量:1

MicroRNA-21 antisense oligonucleotides to inhibit the growth of EC9706 cells
原文传递
导出
摘要 目的 观察微小RNA-21 (miRNA-21)反义寡核苷酸对食管癌EC9706细胞的生长抑制作用.方法 反义寡核苷酸转染食管癌EC9706细胞,噻唑蓝(MTT)法检测细胞生长抑制率,实时荧光定量聚合酶链反应(FQ-PCR)检测细胞miRNA-21水平,流式细胞仪检测细胞凋亡,FQ-PCR检测程序性细胞死亡因子4 (PDCD4) mRNA表达水平,免疫荧光检测PDCD4蛋白表达.结果 反义寡核苷酸抑制细胞活性的最佳浓度为0.5 μmol/L,转染反义寡核苷酸后细胞内miRNA-21的表达水平明显下调为无义组的0.045 ±0.021,细胞凋亡明显增加为12.95%,生存率显著降低为(48.21±9.56)%,差异有统计学意义(P<0.05).反义寡核苷酸组中PDCD4 mRNA相对表达增高为0.452±0.002,且蛋白质表达水平增高,差异有统计学意义(P<0.05).结论 miRNA-21反义寡核苷酸可通过上调PDCD4有效抑制食管癌EC9706细胞增殖并促进凋亡. Objective To observe microRNA (miRNA)-21 antisense oligonucleotide inhibition of the growth of EC9706 cells.Methods Antisense oligonucleotides of EC9706 cells,tetrazolium blue (MTT) assay of cell growth inhibition rate,real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) miRNA-21 level detection cell apoptosis by flow cytometry,FQ-PCR programmed cell death 4 (PDCD4) mRNA expression levels,immunofluorescence PDCD4 protein expression.Results The optimum concentration of antisense oligonucleotide inhibits cell activity was 0.5 μmol/L,after transfection of antisense oligonucleotide expression levels of intracellular miRNA-21 significantly lower for non-defined group of 0.045 ± 0.021,apoptosis a significant increase of 12.95%,the survival rate was significantly lower (48.21 ±9.56)%,the difference was statistically significant (P 〈0.05).Antisense oligonucleotides group PDCD4 mRNA expression increased relative to 0.452 ± 0.002,and increased protein expression levels,and the difference was statistically significant (P 〈 0.05).Conclusion miRNA-21 antisense oligonucleotides can increase PDCD4 of EC9706 effectively inhibit cell proliferation and induce apoptosis.
作者 潘雪 李向楠
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第1期81-83,共3页 Chinese Journal of Experimental Surgery
基金 河南省教育厅科技攻关计划资助项目(12A320032)
关键词 微小RNA-21 食管癌 反义寡核苷酸 程序性细胞死亡因子4 MicroRNA - 21 Esophageal cancer Antisense oligonucleotide Programmed cell death 4
  • 相关文献

参考文献6

二级参考文献55

共引文献75

同被引文献19

  • 1Shirai K, Tamaki Y, Kitamoto Y, et al. Prognosis was not de- teriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy[J]. J Radiat Res, 2013, 54 (4): 706-711.
  • 2Tomimaru Y, Eguchi H, Nagano H, et al. Circulating mi- croRNA-21 as a novel biomarker for hepatocellular carcino- ma[J]. J Hepatol, 2012, 56(1):167-175.
  • 3Hari DM, Leung AM, Lee JH. et al. AJCC cancer staging manual 7th edition criteria for colon cancer: Do the com- plex modifications improve prognostic assessment?[J]. J Am Coil Surg, 2013, 217(2): 181-190.
  • 4Atsumi K, Shioyama Y, Arimura H, et al. Esophageal steno- sis associated with tumor regression in radiotherapy for esophageal cancer: frequency Oncol Biol Phys, 2012, 82(5) and prediction[J]. Int J Radiat 1973-1980.
  • 5Nomura M, Shitara K, Kodaira T, et al. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy[J]. Int J Radiat Oncol Biol Phys, 2012, 82(2): 946-952.
  • 6Swisher SG, Winter KA, Komaki RU, et al. A phase II study of a paclitaxel-based chemoradiation regimen with se- lective surgical salvage for resectable locoregionally ad- vanced esophageal cancer: Initial reporting of RTOG 0246 [J]. lnt J Radiat Oncol Biol Phys, 2012, 82(5): 1967-1972.
  • 7Caponi S, Funel N, Frampton AE, et al. The good, the bad and the ugly: A tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms[J]. Ann Oncol, 2013, 24(3): 734-741.
  • 8Androsavich JR, Chau BN, Bhat B, et al. Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver[J]. RNA, 2012, 18(8): 1510-1526.
  • 9Okayama H, Saito M, Oue N, et al. NOS2 enhances KRAS- induced lung carcinogenesis, inflammation and microRNA- 21 expression[J]. Int J Cancer, 2013, 132( 1 ): 9-18.
  • 10Liu ZL, Wang H, Liu J, et al. MicroRNA-21 (miR-21) ex- pression promotes growth, metastasis, and chemo- or ra- dioresistance in non-small cell lung cancer cells by target- ing PTEN [J]. Mol Cell Biochem, 2013, 372(I-2): 35-45.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部